ATLANTA—A component of red wine and grapes can help control inflammation induced by a bacterial pathogen that is linked to upper respiratory tract inflammatory diseases such as asthma, chronic obstructive pulmonary diseases (COPD) and middle ear infection (otitis media), according to a study by researchers at Georgia State University.
The Center for Inflammation, Immunity & Infection was established in January 2011 as the first University-level multidisciplinary research center at Georgia State University. The Center’s research takes advantage of extraordinary, collective strength in the areas of inflammation, immunity and infection at Georgia State.
ATLANTA—The Georgia State University Research Foundation (GSURF) created a licensing and sponsored research agreement with Aviragen Therapeutics, Inc., to develop the next generation of antivirals commercialize respiratory syncytial virus (RSV) replication inhibitors.
ATLANTA—Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.8-million federal grant to study how changes in intestinal bacteria could lead to obesity and metabolic syndrome.
ATLANTA—Edible ginger-derived nano-lipids created from a specific population of ginger nanoparticles show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer, according to a study by researchers at the Institute for Biomedical Sciences at Georgia State University,